Today: 15 March 2026
Browse Category

Stock Market 14 December 2025

CoreWeave Stock (CRWV) News, Forecasts and Analysis: Convertible Notes, Credit Ratings, and New AI Cloud Deals (Dec. 14, 2025)

CoreWeave Stock (CRWV) News, Forecasts and Analysis: Convertible Notes, Credit Ratings, and New AI Cloud Deals (Dec. 14, 2025)

CoreWeave (NASDAQ: CRWV) closed at $78.59 Friday after completing a $2.59 billion convertible-notes sale, including a full option exercise. Shares swung between $77.71 and $87.60 during the session. The company announced new AI cloud contracts and enterprise tools. Analysts remain divided, citing strong demand but ongoing concerns over leverage and dilution.
14 December 2025
JPMorgan Chase (JPM) Stock News Today: $105B 2026 Expense Outlook, Dividend Update, and Analyst Price Targets (Dec. 14, 2025)

JPMorgan Chase (JPM) Stock News Today: $105B 2026 Expense Outlook, Dividend Update, and Analyst Price Targets (Dec. 14, 2025)

JPMorgan Chase shares closed Friday near $318, just below their 52-week high, after management projected 2026 expenses of about $105 billion—well above analyst expectations. The stock dropped 4–5% following the announcement, marking its sharpest decline in months. Investors are weighing the impact of increased spending on AI, marketing, and expansion ahead of upcoming earnings.
14 December 2025
GE Vernova Stock (GEV) News & Forecasts: Investor Update Rally Meets Valuation Reality as AI Power Demand Resets the Narrative

GE Vernova Stock (GEV) News & Forecasts: Investor Update Rally Meets Valuation Reality as AI Power Demand Resets the Narrative

GE Vernova stock hit a record $731.00 on Dec. 10 after the company raised 2026–2028 revenue and cash flow targets, doubled its dividend, and expanded buybacks. Shares then fell 4.61% to $671.71 by Dec. 12 as analysts debated future upside. Management now projects 2028 revenue of $52 billion. The company is also working with the U.S. government to address rare-earth supply risks.
14 December 2025
Eli Lilly Stock (LLY) News, Forecasts and Analyst Outlook — Retatrutide Breakthrough, Orforglipron FDA Timeline, and a $6B Manufacturing Bet (Dec. 14, 2025)

Eli Lilly Stock (LLY) News, Forecasts and Analyst Outlook — Retatrutide Breakthrough, Orforglipron FDA Timeline, and a $6B Manufacturing Bet (Dec. 14, 2025)

Eli Lilly shares last closed at $1,027.51 as investors weigh advances in obesity drugs and new manufacturing plans. Retatrutide, the company’s next-generation obesity treatment, showed 28.7% average weight loss in a Phase 3 trial, with more studies due in 2026. Lilly also announced a $6 billion API plant in Alabama. Orforglipron, an oral obesity drug, may see an accelerated FDA review.
Lululemon Stock (NASDAQ: LULU) News, Forecasts and Analysis for Dec. 14, 2025: CEO Exit, Q3 Beat, Buyback Boost and Nasdaq-100 Removal

Lululemon Stock (NASDAQ: LULU) News, Forecasts and Analysis for Dec. 14, 2025: CEO Exit, Q3 Beat, Buyback Boost and Nasdaq-100 Removal

Lululemon said CEO Calvin McDonald will step down in January 2026 and reported Q3 revenue up 7% to $2.6 billion, with international sales rising 33% but Americas revenue down 2%. The company will be removed from the Nasdaq-100 on December 22, 2025. Shares traded near $204.97 after the news. Gross margin fell to 55.6%, and operating income dropped 11%.
14 December 2025
Costco Stock (COST) News, Forecasts and Analyst Targets for Dec. 14, 2025: Earnings Beat, Valuation Debate, and Tariff Lawsuit in Focus

Costco Stock (COST) News, Forecasts and Analyst Targets for Dec. 14, 2025: Earnings Beat, Valuation Debate, and Tariff Lawsuit in Focus

Costco closed at about $884 on Friday, Dec. 12, 2025, after reporting Q1 FY2026 net sales of $65.98 billion, up 8.2% year over year, and diluted EPS of $4.50. Shares traded in the high-$860s to high-$880s for the week, with muted reaction despite the earnings beat. Investors are watching valuation debates and a pending tariff lawsuit.
Netflix Stock (NFLX) Forecast and News: Warner Bros Deal, Paramount Hostile Bid, and Analyst Targets as of Dec. 14, 2025

Netflix Stock (NFLX) Forecast and News: Warner Bros Deal, Paramount Hostile Bid, and Analyst Targets as of Dec. 14, 2025

Netflix closed at $95.19 on Friday, down nearly 14.5% over the past month, as investors react to its $82.7 billion bid for Warner Bros. Discovery’s studios and streaming assets. Paramount launched a hostile counterbid, escalating the deal’s antitrust and political risks. The proposed transaction would give WBD shareholders $23.25 in cash and $4.50 in Netflix stock per share. Completion depends on regulatory and shareholder approval.
Micron Technology (MU) Stock News and Forecast for Dec. 14, 2025: Earnings Countdown, AI Memory Shortage, and Wall Street’s New Price Targets

Micron Technology (MU) Stock News and Forecast for Dec. 14, 2025: Earnings Countdown, AI Memory Shortage, and Wall Street’s New Price Targets

Micron shares closed at $241.14 on Friday, Dec. 12, 2025, down 6.7% ahead of its earnings report scheduled for Dec. 17. The company faces high expectations amid a global memory supply crunch driven by AI demand, with analysts raising targets and options markets pricing in a possible double-digit move post-earnings. Investors are watching HBM and DRAM pricing, gross margins, and 2026 supply signals.
Alphabet Class C Stock (GOOG) News and Forecasts: AI Overviews, Cloud Capex, and Antitrust Risks (Dec. 14, 2025)

Alphabet Class C Stock (GOOG) News and Forecasts: AI Overviews, Cloud Capex, and Antitrust Risks (Dec. 14, 2025)

Alphabet’s GOOG shares hovered near $310, just below a recent 52-week high, with a market value close to $2.94 trillion. Investors weighed strong AI and cloud growth against mounting antitrust scrutiny in the EU and U.S. The European Commission opened a new probe into Google’s use of publisher content for AI, raising concerns over compensation and opt-out options.
Palantir (PLTR) Stock News & Forecasts for Dec. 14, 2025: $448M Navy ShipOS, Nvidia “Chain Reaction,” and What Analysts See Next

Palantir (PLTR) Stock News & Forecasts for Dec. 14, 2025: $448M Navy ShipOS, Nvidia “Chain Reaction,” and What Analysts See Next

Palantir closed at $183.57 on Dec. 12, 2025, down 2.12% after a volatile week. The company secured a U.S. Navy ShipOS contract worth up to $448 million and announced a new AI infrastructure platform with Nvidia and CenterPoint. Palantir also filed a lawsuit against a rival startup. Market cap stands at $437.53 billion, with shares up 153% over the past year.
14 December 2025
AMD Stock News and Forecasts (Dec. 14, 2025): What’s Driving Advanced Micro Devices (NASDAQ: AMD) and What Analysts Expect Next

AMD Stock News and Forecasts (Dec. 14, 2025): What’s Driving Advanced Micro Devices (NASDAQ: AMD) and What Analysts Expect Next

AMD shares closed at $210.78 on Dec. 14, down 4.8% after a volatile session tied to a broader selloff in AI-related hardware stocks. The drop followed margin warnings from Broadcom and spending concerns at Oracle, which triggered a wider retreat in the sector. No AMD-specific news drove the decline. Investors remain focused on AI demand and upcoming earnings.
Amazon Stock (AMZN) News, Forecasts, and Analyst Outlook on Dec. 14, 2025: OpenAI Deal, AWS re:Invent AI Push, and What Investors Are Watching

Amazon Stock (AMZN) News, Forecasts, and Analyst Outlook on Dec. 14, 2025: OpenAI Deal, AWS re:Invent AI Push, and What Investors Are Watching

Amazon.com shares closed at $226.19 on Dec. 12, 2025, up 3.1% year-to-date but below the 52-week high of $258.60. Investors are weighing strong AI-driven cloud demand against rising infrastructure costs. A $38 billion, seven-year AWS deal with OpenAI was announced in November. Regulatory issues and delivery cost concerns remain in focus.
Microsoft Stock (MSFT) News, Forecasts & Analysis for Dec. 14, 2025: AI Mega-Investments, Azure Momentum, and Wall Street’s $630–$650 Targets

Microsoft Stock (MSFT) News, Forecasts & Analysis for Dec. 14, 2025: AI Mega-Investments, Azure Momentum, and Wall Street’s $630–$650 Targets

Microsoft shares last traded near $478.53 as of Dec. 14, 2025, after announcing $23 billion in new AI infrastructure spending, including $17.5 billion for India and $5.4 billion for Canada. The stock remains volatile, with a 52-week range from $344.79 to $555.45. Investors are weighing rising capital expenditures against strong Azure and Copilot demand.
Oracle Stock (ORCL) Outlook on Dec. 14, 2025: AI Spending Shock, OpenAI Data Center Delays, and Wall Street Forecasts

Oracle Stock (ORCL) Outlook on Dec. 14, 2025: AI Spending Shock, OpenAI Data Center Delays, and Wall Street Forecasts

Oracle shares closed at $189.97, down 4.56% after fiscal Q2 results beat earnings estimates but raised concerns over AI infrastructure spending and slower revenue conversion. Analyst consensus remains “Moderate Buy,” with average 12-month price targets near $300. Oracle’s Q3 guidance missed expectations, projecting adjusted EPS of $1.64–$1.68 and revenue growth of 16%–18%.
NVIDIA Stock (NVDA) News Today: China H200 Export Shift, AI Spending Jitters, and Wall Street Forecasts (Dec. 14, 2025)

NVIDIA Stock (NVDA) News Today: China H200 Export Shift, AI Spending Jitters, and Wall Street Forecasts (Dec. 14, 2025)

Nvidia shares closed Friday at $175.02 after a volatile week for AI chip stocks. The U.S. will allow exports of Nvidia’s H200 AI processors to China with a 25% import fee, but not its newest Blackwell or Rubin chips. Nvidia is considering increasing H200 production as Chinese demand exceeds supply. The Commerce Department is finalizing export terms.
14 December 2025
Tesla Stock News and Forecasts for Dec. 14, 2025: Robotaxi Countdown, Sales Signals, and Wall Street Targets for TSLA

Tesla Stock News and Forecasts for Dec. 14, 2025: Robotaxi Countdown, Sales Signals, and Wall Street Targets for TSLA

Tesla closed Friday at $458.96, rising 2.7% amid renewed focus on autonomy and robotics. Elon Musk said Tesla may remove safety monitors from its Austin robotaxi fleet within three weeks. U.S. November sales dropped nearly 23% year over year to about 39,800 vehicles, the lowest since early 2022. A recent analyst downgrade has fueled debate over the company’s valuation.
Exxon Mobil (XOM) Stock Outlook: 2030 Plan Lifts Targets, Analysts Raise Price Goals — What to Watch This Week (Updated Dec. 14, 2025)

Exxon Mobil (XOM) Stock Outlook: 2030 Plan Lifts Targets, Analysts Raise Price Goals — What to Watch This Week (Updated Dec. 14, 2025)

Exxon Mobil shares rallied midweek after the company raised its 2030 earnings and cash flow targets while keeping capital spending flat. XOM last traded near $118.82. The plan calls for $25 billion in earnings growth and $35 billion in cash flow by 2030, with annual capex held at $28–$33 billion. Shares steadied just below $120 by Friday’s close.
14 December 2025
Novo Nordisk Stock (NOVO-B, NVO) Update Dec 14, 2025: Wegovy 7.2 mg Tailwind, Ozempic India Launch, Akero Deal — Outlook for the Week Ahead

Novo Nordisk Stock (NOVO-B, NVO) Update Dec 14, 2025: Wegovy 7.2 mg Tailwind, Ozempic India Launch, Akero Deal — Outlook for the Week Ahead

Novo Nordisk shares rebounded this week, rising about 7% in both Copenhagen and U.S. trading after EU regulators backed a higher-dose Wegovy, Ozempic launched in India at a lower price, and the company closed its Akero Therapeutics acquisition. The week began with a sharp selloff on competition fears and a Wall Street downgrade before sentiment reversed midweek.

Stock Market Today

  • ASX Technical Scan Highlights Uptrends in Droneshield, Electro Optic Systems, Dateline Resources
    March 15, 2026, 6:23 PM EDT. The latest ChartWatch ASX technical scan identifies significant uptrends in stocks such as Droneshield (DRO), Electro Optic Systems (EOS), and Dateline Resources (DTR). Droneshield surged 35.8%, EOS climbed 91.2%, and Dateline Resources jumped 38.3%, signaling strong investor interest. Other notable performers include Lindian Resources and Omega Oil & Gas, benefiting from sustained buying pressure. The scan uses trend following methodology to alert traders to robust market moves. Meanwhile, a downtrend list flags stocks like Alliance Aviation Services and Bapcor facing heavy declines. Investors are encouraged to apply these lists flexibly to guide buy, sell, or short strategies. For further insights, ChartWatch offers weekly live webinars with technical analyst Carl Capolingua, providing detailed case studies on ASX stock trends.
Go toTop